glp 1 agonist gastroparesis Beyond Weight Loss: ED Implications of the GLP-1 Era Glucagon-Like Peptide 1 Receptor Agonists

Dietary Implications of the Bidirectional Relationship between the Gut Microflora and Inflammatory Diseases with Special Emphasis on Irritable Bowel Disease: Current and Future Perspective

Proc Natl Acad Sci U S A (1996) 93(1):26973

Use With Caution / Additional Monitoring in Research Contexts Because Ipamorelin is researched for its interaction with growth hormone and IGF-1 signaling pathways, caution is advised in research models involving endocrine, metabolic, cardiovascular, or proliferative conditions

The peptide was originally developed by researchers seeking to isolate the lipolytic effects of growth hormone from its other physiological actions